| Dr Thomas Harmon Castle Jr, MD | |
|
1231 116th Ave Ne, Suite 750, Bellevue, WA 98004-3804 | |
| (425) 455-3600 | |
| (425) 455-3920 |
| Full Name | Dr Thomas Harmon Castle Jr |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1231 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881665677 | NPI | - | NPPES |
| 0122276 | Other | WA | L & I |
| GAB04792 | Other | WA | MEDICARE POSM |
| 200034303 | Other | WA | MEDICARE RR KING CO. |
| G8853678 | Other | WA | MEDICARE EMRI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00025341 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Harmon Castle Jr, MD 805 Madison St, Suite 901, Seattle, WA 98104-1172 Ph: (206) 264-8100 | Dr Thomas Harmon Castle Jr, MD 1231 116th Ave Ne, Suite 750, Bellevue, WA 98004-3804 Ph: (425) 455-3600 |
News Archive
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its second quarter 2010 results.
Palos Community Hospital and Loyola University Medical Center announced April 2 plans to join together to create an innovative affiliation in Illinois. With a focus on coordinated and collaborative patient care, the affiliation presents a new way to build a network of care that doesn't involve mergers, acquisitions or consolidations, a trend in today's evolving health care landscape.
Results of an EORTC trial appearing in The Lancet Oncology show that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence, but that this treatment was also associated with a high rate of immune-related adverse events.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States.
› Verified 3 days ago
Michael J Battaglia Ii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Dr. Lance S Ho, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Dean S Ricketts, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1231 116th Ave Ne, Suite 100, Bellevue, WA 98004 Phone: 425-454-5344 Fax: 425-462-0763 | |
Dr. Thomas E Trumble, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 112th Ave Ne Ste C210, Bellevue, WA 98004 Phone: 425-999-3580 Fax: 425-999-3122 | |
Mary Kathryn Thayer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Northup Way Ste 201, Bellevue, WA 98004 Phone: 425-455-3600 Fax: 425-455-3920 | |
Alan Burchard Brown, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Matthew Lawrence Lyons, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3700 Fax: 425-502-3701 |